Albany, NY -- (SBWIRE) -- 09/10/2019 -- Cataract Surgery Complications Market Insights, Epidemiology and Market Forecast-2028
1. A decreased visual acuity induced by posterior capsular opacification reported to occur in 20–40% of patients 2–5 years after surgery.
2. 43% of their patients require discission, with an average follow-up of 26 months and a range from 3 months to 4 years.
3. Corneal transplantation in the United States as 26,509 procedures (40% of all transplantations) were performed in 2013.
DelveInsight launched a new report on Cataract Surgery Complications Market Insights, Epidemiology and Market Forecast-2028
Key benefits
1. Cataract Surgery Complications market report covers a descriptive overview and comprehensive insight of the Cataract Surgery Complications epidemiology and Cataract Surgery Complications market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. Cataract Surgery Complications market report provides insights on the current and emerging therapies.
3. Cataract Surgery Complications market report provides a global historical and forecasted market covering drug outreach in 7 MM.
4. Cataract Surgery Complications market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Cataract Surgery Complications market.
Request for sample pages
"Cataract prevalence shows that nearly 30% proportion of the population older than 65 would benefit from surgery."
Cataract surgery is a procedure to remove the lens of the eye and, in most cases, replace it with an artificial lens. It involves removal of the clouded (cataractous) lens in its entirety via surgery and replacement of the lens with an intraocular lens (IOL) made of plastic. While cataract surgery is one of the safest procedures available with a high rate of success, rare complications, such as infection (endophthalmitis) or bleeding can arise. The most common difficulties arising after surgery are persistent inflammation, changes in eye pressure (glaucoma), infection, or swelling of the retina at the back of the eye (cystoid macular edema), and retinal detachment. All of these complications are rare but can lead to significant visual loss; thus, close follow-up is required after surgery.
Corneal endothelial dysfunction occurs when corneal endothelial cells (CECs) are dramatically lost and eventually results in vision loss. At present, the only solution is corneal transplantation. As corneal transplantation requires a fresh human cornea which has a worldwide shortage of donors. The other alternative for such a situation is the use of Skin-derived precursors (SKPs). SKPs can be isolated in large quantities from many parts of the skin in humans. As they are multipotent, they can be differentiated into several functional cell types, and are able to suppress the allogeneic activation of T-lymphocytes resulting in the improved health status of animals suffering from a graft-versus-host reaction. Moreover, other surgical options include Descemet's stripping endothelial keratoplasty (DSEK) and Descemet's membrane endothelial keratoplasty (DMEK) which are used to treat corneal endothelial dysfunction. Descemet stripping endothelial keratoplasty (DSEK) is a type of endothelial keratoplasty (EK) procedure where the host endothelium and Descemet's membrane (DM) are replaced by the donor endothelium and DM, along with a small amount of posterior stromal thickness, through a corneal or corneoscleral incision. DMEK is a partial-thickness corneal transplant procedure that involves selective removal of the patient's Descemet membrane and endothelium, followed by transplantation of donor corneal endothelium and Descemet membrane without additional stromal tissue from the donor.
Overall, the Cataract surgery complications therapeutics market is further expected to increase by the major drivers, such as rising Incident population, technological advancements, and upcoming therapies in the forecast period [2019–2028].
The launch of the emerging therapies is expected to significantly impact Cataract Surgery Complications treatment scenario in the upcoming years:-
Drugs covered
1. ST266
And many others
The key players in Cataract Surgery Complications market are:
1. Noveome Biotherapeutics,
2. Zion Therapeutics
3. Dompé Farmaceutici
And many others
Table of contents
1. Report Introduction
2. Cataract Surgery Complications Market Overview at a Glance
3. Cataract Surgery Complications Disease Background and Overview
4. Cataract Surgery Complications Epidemiology and Patient Population (7MM)
5. Cataract Surgery Complications Country-Wise Epidemiology
5.1. United States
5.2. EU5 Countries
5.3. Germany
5.4. France
5.5. Italy
5.6. Spain
5.7. United Kingdom
5.8. Japan
6. Cataract Surgery Complications Treatments & Medical Practices
7. Cataract Surgery Complications Emerging Therapies
7.1. Key Cross Competition
7.2. ST266: Noveome Biotherapeutics
8. Total 7MM Cataract Surgery Complications Market Analysis
9. Cataract Surgery Complications Country-Wise Market Analysis 7MM
10. United States Market Size
11. EU5 Market Size
11.1.Germany Market Size
11.2.France Market Size
11.3.Italy Market Size
11.4.Spain Market Size
11.5.United Kingdom Market Size
12. Japan Market Size
13. Market Drivers
14. Market Barriers
15. Cataract Surgery Complications Report Methodology
16. DelveInsight Capabilities
17. Disclaimer
18. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Contact us:
Shruti Thakur
info@delveinsight.com
+919650213330
SOURCE DelveInsight